Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

758 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study.
Podzamczer D, Rozas N, Domingo P, Ocampo A, Van den Eynde E, Deig E, Vergara A, Knobel H, Pasquau J, Antela A, Crespo M, Clotet B, Muñoz J, Fernandez P, Geijo P, de Castro ER, Diz J, Casado A, Torres C. Podzamczer D, et al. Among authors: domingo p. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19814. doi: 10.7448/IAS.17.4.19814. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397558 Free PMC article.
Twice-weekly maintenance therapy with sulfadiazine-pyrimethamine to prevent recurrent toxoplasmic encephalitis in patients with AIDS. Spanish Toxoplasmosis Study Group.
Podzamczer D, Miró JM, Bolao F, Gatell JM, Cosín J, Sirera G, Domingo P, Laguna F, Santamaría J, Verdejo J. Podzamczer D, et al. Among authors: domingo p. Ann Intern Med. 1995 Aug 1;123(3):175-80. doi: 10.7326/0003-4819-123-3-199508010-00003. Ann Intern Med. 1995. PMID: 7598298 Clinical Trial.
Thrice-weekly sulfadiazine-pyrimethamine for maintenance therapy of toxoplasmic encephalitis in HIV-infected patients. Spanish Toxoplasmosis Study Group.
Podzamczer D, Miró JM, Ferrer E, Gatell JM, Ramón JM, Ribera E, Sirera G, Cruceta A, Knobel H, Domingo P, Polo R, Leyes M, Cosin J, Fariñas MC, Arrizabalaga J, Martínez-Lacasa J, Gudiol F. Podzamczer D, et al. Among authors: domingo p. Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):89-95. doi: 10.1007/s100960050436. Eur J Clin Microbiol Infect Dis. 2000. PMID: 10746493 Clinical Trial.
Hepatitis C virus and human immunodeficiency virus coinfection in Spain.
Roca B, Suarez I, Gonzalez J, Garrido M, de la Fuente B, Teira R, Geijo P, Cosin J, Perez-Cortes S, Galindo MJ, Lozano F, Domingo P, Viciana P, Ribera E, Vergara A, Sánchez T. Roca B, et al. Among authors: domingo p. J Infect. 2003 Aug;47(2):117-24. doi: 10.1016/s0163-4453(03)00067-7. J Infect. 2003. PMID: 12860144
Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.
Martínez E, Arnaiz JA, Podzamczer D, Dalmau D, Ribera E, Domingo P, Knobel H, Riera M, Pedrol E, Force L, Llibre JM, Segura F, Richart C, Cortés C, Javaloyas M, Aranda M, Cruceta A, de Lazzari E, Gatell JM; Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team. Martínez E, et al. Among authors: domingo p. N Engl J Med. 2003 Sep 11;349(11):1036-46. doi: 10.1056/NEJMoa021589. N Engl J Med. 2003. PMID: 12968087 Free article. Clinical Trial.
Failure of cetirizine to prevent nevirapine-associated rash: a double-blind placebo-controlled trial for the GESIDA 26/01 Study.
Knobel H, Miró JM, Mahillo B, Domingo P, Rivero A, Ribera E, Gonzalez J, Sanz J, González A, Blanco JL, Boix V, Force L, Llibre JM, Dalmau D, Arroyo JA, De la Torre J, Rodriguez D, Montes ML, Arranz A, Sarasa M; Grupo Estudio Syndrome Immunodeficiencies Adquirida 26/02 Study Group. Knobel H, et al. Among authors: domingo p. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1276-81. doi: 10.1097/01.qai.0000137372.18814.34. J Acquir Immune Defic Syndr. 2004. PMID: 15385735 Clinical Trial.
[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)].
Teira R, Suárez-Lozano I, Muñoz P, Viciana P, Lozano F, Galindo MJ, Terrón A, Vergara A, Geijo P, Arribas JR, Cosín J, Domingo P, Ribera E, Roca B, García-Alcalde ML, Sánchez T, Muñoz-Sanz A. Teira R, et al. Among authors: domingo p. Enferm Infecc Microbiol Clin. 2005 Apr;23(4):213-7. doi: 10.1157/13073147. Enferm Infecc Microbiol Clin. 2005. PMID: 15826546 Spanish.
Spanish HIV-1-infected long-term nonprogressors of more than 15 years have an increased frequency of the CX3CR1 249I variant allele.
Vidal F, Viladés C, Domingo P, Broch M, Pedrol E, Dalmau D, Knobel H, Peraire J, Gutiérrez C, Sambeat MA, Fontanet A, Deig E, Cairó M, Montero M, Richart C, Mallal S; Chemokines LTNP Study Group. Vidal F, et al. Among authors: domingo p. J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):527-31. doi: 10.1097/01.qai.0000186362.50457.e0. J Acquir Immune Defic Syndr. 2005. PMID: 16284527
758 results